Home
Tarsus Pharmaceuticals TARS paid Forbes-Tate $50K for lobbying in Q2 2026 · Health Issues
Trade details
- Type
- Lobbying report
- Amount
- $50,000
- Quarter
- Q2 2026
- Client
- Tarsus Pharmaceuticals
- Reported
- 26/07/20
Up 0.0% from last quarter
What else happened in Tarsus Pharmaceuticals around then
Filed or reported within 30 days of the trade day · 05/31~07/30Tarsus Pharmaceuticals's other lobbying reports
- Tarsus Pharmaceuticals
LobbyingTarsus Pharmaceuticals
LobbyingTarsus Pharmaceuticals
TARS
$50K
$50K
Reported 04/19
for Q1
- Tarsus Pharmaceuticals
LobbyingTarsus Pharmaceuticals
LobbyingTarsus Pharmaceuticals
TARS
$50K
$50K
Reported 01/17
for Q4 2025
- Tarsus Pharmaceuticals
LobbyingTarsus Pharmaceuticals
LobbyingTarsus Pharmaceuticals
TARS
$50K
$50K
Reported 25/10/18
for Q3 2025
- Tarsus Pharmaceuticals
LobbyingTarsus Pharmaceuticals
LobbyingTarsus Pharmaceuticals
TARS
$50K
$50K
Reported 25/07/17
for Q2 2025
- Tarsus Pharmaceuticals
LobbyingTarsus Pharmaceuticals
LobbyingTarsus Pharmaceuticals
TARS
$50K
$50K
Reported 25/04/21
for Q1 2025